Description of a tall-man lettering program for look-alike and sound-alike antineoplastic agents
Authors:
- 15 April 2018
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 75 (8) , 512-513
Abstract
Tall-man (i.e., mixed-case) lettering is used to highlight dissimilarities in look-alike and sound-alike (LASA) drug names.1 Studies have shown that emphasizing definitive sections of drug names using capitalized letters can help distinguish between similar looking and sounding medications (e.g., vinBLAStine, vinCRIStine), making them less prone to mistake for one another and thereby reducing medication errors.2,3 Despite the benefits of tall-man lettering and its endorsement by the Institute for Safe Medication Practices, Food and Drug Administration, Joint Commission, and National Association of Boards of Pharmacy, there is a lack of definitive standard guidance regarding its use.Keywords
This publication has 4 references indexed in Scilit:
- Automated detection of look-alike/sound-alike medication errorsAmerican Journal of Health-System Pharmacy, 2017
- Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive studyBMJ Quality & Safety, 2015
- Tall Man lettering and potential prescription errors: a time series analysis of 42 children's hospitals in the USA over 9 yearsBMJ Quality & Safety, 2015
- Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement dataSocial Science & Medicine, 2004